EMEA-002232-PIP02-19-M02
Key facts
| Active substance |
Bis-choline tetrathiomolybdate
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/0164/2022
|
| PIP number |
EMEA-002232-PIP02-19-M02
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of Wilson Disease
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Alexion Europe SAS
E-mail: pip.enquiries.eu@alexion.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|